Teratogenic medications are commonly prescribed to women of reproductive age. Caring for women who may benefit from the use of teratogenic medications requires clinicians to engage patients in ...

Nearly 40% of pregnancy-capable patients with rheumatic disease are unaware of the potential impacts of their medications on ...

More information: Anna Kemp‐Casey et al, Are assisted reproductive technology pregnancies more likely to be exposed to teratogenic medication? A whole‐population study, Australian and New ...

However, overall prevalence of exposure to teratogenic medicines is low. (HealthDay News) — Pregnancies resulting from assisted reproductive technology (ART) have a higher prevalence of exposure ...

Teratogenic substances, such as certain medications, alcohol, tobacco smoke, and illicit drugs, pose a risk to the developing ...

There is a lack of information on the effects of aflatoxins on the fetus. Our aim was to evaluate the consequences of aflatoxin B1 (AFB1) administered during early and late gestation on fetal ...

The fundamental initial steps in caring for women of reproductive age who are candidates for teratogenic medications include recognition of a medication as a potential teratogen and assessing a ...